Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwenan M Knight

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Vaccine|November 7, 2016
The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisionsSophie J Rhodes, Andrea Zelmer, Gwenan M Knight, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
BMC Medicine|August 24, 2018
Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling studyGwenan M Knight, Céire Costelloe, Sarah R Deeny, et al.
Frontiers in Public Health|August 29, 2022
Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in EnglandNichola R Naylor, Stephanie Evans, Koen B Pouwels, et al.
Plos Medicine|November 4, 2025
Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling studyNaomi R Waterlow, Clare I R Chandler, Ben S Cooper, et al.
Plos One|September 11, 2019
The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort studyNichola R Naylor, Koen B Pouwels, Russell Hope, et al.
Npj Antimicrobials and Resistance|May 9, 2025
Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillanceKathryn E Holt, Megan E Carey, Clare Chandler, et al.
BMC Infectious Diseases|April 2, 2022
Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling studyAlicia Rosello, Rosanna C Barnard, David R M Smith, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2017
Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling MethodsSophie J Rhodes, Charlotte Sarfas, Gwenan M Knight, et al.
BMC Health Services Research|June 10, 2021
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in EnglandQuentin J Leclerc, Naomi M Fuller, Ruth H Keogh, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Vaccine|November 7, 2016
The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisionsSophie J Rhodes, Andrea Zelmer, Gwenan M Knight, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
BMC Medicine|August 24, 2018
Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling studyGwenan M Knight, Céire Costelloe, Sarah R Deeny, et al.
Frontiers in Public Health|August 29, 2022
Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in EnglandNichola R Naylor, Stephanie Evans, Koen B Pouwels, et al.
Plos Medicine|November 4, 2025
Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling studyNaomi R Waterlow, Clare I R Chandler, Ben S Cooper, et al.
Plos One|September 11, 2019
The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort studyNichola R Naylor, Koen B Pouwels, Russell Hope, et al.
Npj Antimicrobials and Resistance|May 9, 2025
Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillanceKathryn E Holt, Megan E Carey, Clare Chandler, et al.
BMC Infectious Diseases|April 2, 2022
Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling studyAlicia Rosello, Rosanna C Barnard, David R M Smith, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2017
Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling MethodsSophie J Rhodes, Charlotte Sarfas, Gwenan M Knight, et al.
BMC Health Services Research|June 10, 2021
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in EnglandQuentin J Leclerc, Naomi M Fuller, Ruth H Keogh, et al.
Pageof 8